Fundraising Fox

Centivax

37 employees on LinkedIn · 4 known investors

Centivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.

BiotechHealthtech

Founders & leadership

JGJacob Glanville
Jacob Glanvillein𝕏Founder, CEO & PresidentJacob Glanville is a computational immunologist and the founder and CEO of Centivax, a biotechnology company developing broad-spectrum vaccines and antibody therapeutics, including a universal influenza vaccine. He previously founded the antibody engineering company Distributed Bio, which was acquired in 2020.
SWStephanie Wisner
Stephanie WisnerinCo-Founder, Treasurer, Chief Business OfficerFounder of Centivax, a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine. She authored a book on biotech entrepreneurship, "Building Backwards to Biotech," aimed at introducing readers to the biotech industry.

Investors · 4

Amplify PartnersMenlo Park · $500K – $5M
Bold Capital PartnersSanta Monica
Future VenturesLos Altos · $1M – $10M
NFXSan Francisco · $250K – $5M

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 2

by search overlap
Dynavax NASDAQ: DVAX www.dynavax.com36 shared keywordsDynavax is a commercial-stage biopharmaceutical company that develops and commercializes vaccines against infectious diseases using its adjuvant technology. Its products target immunization and infectious disease prevention.
Outsideonline25 shared keywordsOutside is an online media publication covering outdoor recreation, adventure travel, and related lifestyle topics through articles and travel guides.

Companies competing with Centivax for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Centivax Closes $37 Million Financing to Accelerate Phase 2 Clinical Development of Universal Flu and Advance Follow-On Portfolio to Clinical Readinessprnewswire.com · Mar 2026Centivax Raises $37M in Fundingfinsmes.com · Mar 2026Sell or Invest in Centivax Stock Pre-IPOnasdaqprivatemarket.com · Jul 2025Flu vaccine startup raises $45 million, says tech could eventually tackle COVID, HIVaxios.com · Jul 2025Centivax raises $45M in funding to launch first-ever universal flu vaccine to human trials - Tech Startupstechstartups.com · Jul 2025Centivax Raises Oversubscribed $45 Million Series A Led by Future Ventures to Advance Universal Flu Vaccine into Clinic and Expand Universal Immunity Portfolioprnewswire.com · Jul 2025

Frequently asked questions

What does Centivax do?
Centivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.
Who founded Centivax?
Centivax was founded by Jacob Glanville, Stephanie Wisner.
Who are Centivax's investors?
Centivax's investors include Amplify Partners, Bold Capital Partners, Future Ventures, NFX.